Drug majors Ranbaxy and Merck have called off a deal that would have seen both the pharma giants join hands to research anti-infectives, reports PharmAsia News. The deal between the two companies was struck in 2008. Ranbaxy was to get milestones and an undisclosed upfront fee as part of the deal.
first published: Jan 4, 2011 10:10 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.
